fluorides has been researched along with Leukemia L 1210 in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertino, JR; Nahas, A; Nixon, PF | 1 |
| Baker, BR; Meyer, RB | 4 |
| Baker, BR; Huang, PC | 1 |
| Baker, BR; Vermeulen, NM | 7 |
| Ashton, WT; Baker, BR | 3 |
| Baker, BR; Lourens, GJ | 3 |
| Baker, BR; Lourens, GJ; Meyer, RB; Vermeulen, NM | 1 |
20 other study(ies) available for fluorides and Leukemia L 1210
| Article | Year |
|---|---|
Uptake and metabolism of N 5 -formyltetrahydrofolate by L1210 leukemia cells.
Topics: Animals; Carbon Isotopes; Chloromercuribenzoates; Chromatography, Gel; Coenzymes; Depression, Chemical; Fluorides; Folic Acid; Hydrogen-Ion Concentration; In Vitro Techniques; Iodoacetates; Leukemia L1210; Methotrexate; Mice; Ouabain; Tetrahydrofolates; Tritium | 1972 |
Irreversible enzyme inhibitors. CXIX. Active-site-directed irreversible inhibitors of dihydrofolic reductase with tissue specificity derived from 2,4,6-triaminopyrimidine with a terminal sulfonyl fluoride at the 5 position.
Topics: Animals; Binding Sites; Carcinoma 256, Walker; Fluorides; Folic Acid Antagonists; Leukemia L1210; Liver; Mice; Pyrimidines; Rats; Sulfonic Acids | 1968 |
Irreversible enzyme inhibitors. CXX. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-substituted 2,4-diamino-5-phenylpyrimidines with tissue specificity.
Topics: Animals; Binding Sites; Carcinoma 256, Walker; Fluorides; Folic Acid Antagonists; Leukemia L1210; Liver; Mice; Pyrimidines; Rats; Sulfonic Acids | 1968 |
Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride.
Topics: Animals; Binding Sites; Fluorides; Folic Acid Antagonists; In Vitro Techniques; Leukemia L1210; Liver; Mice; Pyrimidines; Sulfones | 1969 |
Irreversible enzyme inhibitors. CLXXV. Irreversible inhibition of purified dihydrofolic reductase.
Topics: Animals; Carcinoma 256, Walker; Columbidae; Fluorides; Folic Acid Antagonists; Kidney Neoplasms; Leukemia L1210; Liver; Liver Neoplasms; Mice; Rats; Sulfones | 1970 |
Irreversible enzyme inhibitors. CLXXVI. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine by ether bridging to a terminal sulfonyl fluoride.
Topics: Animals; Carcinoma 256, Walker; Ethers; Fluorides; Folic Acid Antagonists; Kidney Neoplasms; Leukemia L1210; Liver; Liver Neoplasms; Mice; Neoplasms, Experimental; Rats; Splenic Neoplasms; Sulfones; Time Factors; Triazines | 1970 |
Irreversible enzyme inhibitors. CLXXIX. Active-site-directed irreversible enzyme inhibitors of dihydrofolate reductase from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with oxyamide bridges to a terminal sulfonyl fluoride.
Topics: Animals; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Culture Techniques; Fluorides; Folic Acid Antagonists; Leukemia L1210; Liver; Mice; Neoplasms, Experimental; Rats; Sulfones; Triazines | 1970 |
Irreversible enzyme inhibitors. 178. Active-site-directed irreversible inhibitors of dihydrofolate reductase derived from 1-(4-benzyloxy-3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine with a terminal sulfonyl fluoride.
Topics: Animals; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Culture Techniques; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Neoplasms, Experimental; Rats; Spleen; Sulfones; Triazines | 1970 |
Irreversible enzyme inhibitors. CXLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[p-(p-fluorosulfonylphenylureidomethyl)phenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Spleen; Sulfonic Acids; Triazines | 1969 |
Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Pyrimidines; Spleen; Sulfonic Acids | 1969 |
Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Culture Techniques; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Pyrimidines; Spleen; Sulfonic Acids | 1969 |
Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Chlorine; Depression, Chemical; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Pyrimidines; Spleen; Sulfonic Acids; Tetrahydrofolate Dehydrogenase; Time Factors; Triazines | 1969 |
Irreversible enzyme inhibitors. CXXXV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(p-fluorosulfonyl-phenylureido)phenoxymeth
Topics: Animals; Benzene Derivatives; Binding Sites; Chemical Phenomena; Chemistry; Chlorine; Fluorides; Folic Acid Antagonists; Leukemia L1210; Liver; Mice; Pyrimidines; Sulfonic Acids | 1969 |
Irreversible enzyme inhibitors. CXXXIV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonyl-phenylureido)phenoxymet
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Chlorine; Fluorides; Folic Acid Antagonists; Leukemia L1210; Liver; Methylation; Mice; Pyrimidines; Sulfonic Acids; Time Factors | 1969 |
Irreversible enzyme inhibitors. CXXXVI. 2,4-Diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenzamido)phenoxymethyl]pyrimidine, an active-site-directed irreversible inhibitor of dihydrofolic reductase. Effect of structure on isozyme specificity.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chlorine; Fluorides; Folic Acid Antagonists; Intestines; Isoenzymes; Leukemia L1210; Liver; Mice; Pyrimidines; Spleen; Sulfonic Acids | 1969 |
Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chemical Phenomena; Chemistry; Chlorine; Fluorides; Folic Acid Antagonists; Isoenzymes; Leukemia L1210; Liver; Mice; Pyrimidines; Sulfonic Acids | 1969 |
Irreversible enzyme inhibitors. 138. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenethyl)-- 2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine with a terminal sulfonyl fluoride.
Topics: Animals; Benzene Derivatives; Binding Sites; Chemical Phenomena; Chemistry; Chlorine; Fluorides; Folic Acid Antagonists; Leukemia L1210; Liver; Methylation; Mice; Pyrimidines; Sulfonic Acids | 1969 |
Irreversible enzyme inhibitors. CXXXIX. p-(4,6-Diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. VI. Further studies on effects of substitution on
Topics: Amides; Animals; Benzene Derivatives; Binding Sites; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Fluorides; Folic Acid Antagonists; Isoenzymes; Leukemia L1210; Liver; Mice; Naphthalenes; Propionates; Rats; Spleen; Sulfonic Acids; Toluene; Triazines | 1969 |
Irreversible enzyme inhibitors. CXL. Active-site-directed irreversible inhibitors derived from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
Topics: Animals; Benzene Derivatives; Binding Sites; Chemical Phenomena; Chemistry; Chlorine; Fluorides; Folic Acid Antagonists; Intestines; Leukemia L1210; Liver; Mice; Spleen; Sulfonic Acids; Triazines | 1969 |
Irreversible enzyme inhibitors. CXXXVI. 2,4-Diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenz amido) phenoxymethyl] pyrimidine, an active-site-directed irreverisible inhibitor of dihydrofolic reductase. Effect of structure on isozyme specificity.
Topics: Animals; Benzene Derivatives; Binding Sites; Carbamates; Chlorine; Fluorides; Folic Acid Antagonists; Intestines; Isoenzymes; Leukemia L1210; Liver; Mice; Pyrimidines; Spleen; Sulfonic Acids | 1969 |